Wright Medical (WMGI) Augment Approval Removes Overhang, Leerink Partners Says
Tweet Send to a Friend
Leerink Partners analyst Richard Newitter reiterated an Outperform rating and $31 price target on Wright Medical (NASDAQ: WMGI), saying Augment ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
